BioSpace News Archive

Genetown

X4 Pharmaceuticals to Present at March Investor Conferences

X4 Pharmaceuticals, Inc. today announced that management will participate in a panel at the 42nd Annual Cowen Healthcare Conference on Monday, March 7, 2022 and in a fireside chat at the 32 nd Annual Oppenheimer Healthcare Conference on Tuesday, March 15, 2022.

March 3, 2022
·
2 min read
Business

Outlook Therapeutics Bolsters Commercialization Expertise with Appointment of Alicia Tozier as Senior Vice President of Marketing and Market Access

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced that Alicia Tozier has been appointed as Senior Vice President, Marketing and Market Access.

March 3, 2022
·
7 min read
Business

Genocea to Host Fourth Quarter 2021 Corporate Update Conference Call & Webcast

Genocea Biosciences, Inc. will host its fourth quarter 2021 financial results and corporate update conference call and live audio webcast on Thursday, March 10th at 8:30 a.m. E.T.

March 3, 2022
·
2 min read
Fortress Biotech Announces Virtual Two-Day Corporate Access Summit Hosted by B. Riley Securities on Tuesday, April 5 and Wednesday, April 6, 2022

Fortress Biotech, Inc. today announced a two-day summit hosted by the B. Riley Securities’ Healthcare Equity Research team, that will feature multiple programs from Fortress’ diversified pipeline.

March 3, 2022
·
4 min read
Athena Bioscience Announces Launch of Nexiclon™ XR, the Only Once-Daily Clonidine Extended-Release Tablets for Treatment of Hypertension

Athena Bioscience, LLC announced plans for the commercial launch of Nexiclon XR, the only once-daily clonidine extended-release tablets indicated for treatment of hypertension.

March 3, 2022
·
3 min read
FDA

I-Mab Receives FDA Orphan Drug Designation for its Novel Claudin 18.2 x 4-1BB Bispecific Antibody TJ-CD4B for the Treatment of Gastric Cancer

I-Mab today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for TJ-CD4B, a novel Claudin 18.2 x 4-1BB.

March 3, 2022
·
6 min read
Pharm Country

ArrePath Announces $20 Million Seed Financing to Advance its Machine Learning-based Platform for Discovery of Novel Anti-infectives Addressing Antimicrobial Resistance

ArrePath, announced today that it has raised $20 million in seed financing to advance its proprietary, machine learning (ML)-based platform for the discovery of new classes of anti-infectives to overcome antimicrobial resistance (AMR).

March 3, 2022
·
8 min read
Eosinophilic Asthma Treatment Market: The nasal segment is projected to be driven by increase in the use of nasal sprays for the treatment of asthma

Albany NY, United States: Asthma associated with high level of eosinophils is known as eosinophilic asthma.

March 3, 2022
·
5 min read
Electronic Skin Patches Market: Increase in geriatric population and rise in chronic illnesses drive the market

Albany NY, United States: Electronic skin patches are considered to be ultimate wearable electronic devices.

March 3, 2022
·
6 min read
Global Electric Dental Handpiece Market Trends, Demand, Potential and Competitive Analysis

The global market for electric dental handpiece is growing due to the rising incidence of oral and dental problems.

March 3, 2022
·
5 min read